TrialBMC cancer2015

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.

Toby A Eyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.